Bio-Rad Laboratories (BIO) Gross Profit (2009 - 2026)

Bio-Rad Laboratories (BIO) has 18 years of Gross Profit data on file, last reported at $309.4 million in Q1 2026.

• On a quarterly basis, Gross Profit rose 1.11% year-over-year to $309.4 million in Q1 2026; TTM through Mar 2026 was $1.3 billion, a 1.16% decrease from a year earlier, with the FY2025 full-year figure at $1.3 billion, down 2.83% from the prior year.
• Gross Profit for Q1 2026 stood at $309.4 million, down from $345.2 million in the prior quarter.
• Over the last five years, Gross Profit for BIO reached as high as $402.6 million in Q1 2022 and fell as low as $306.0 million in Q1 2025.
• Historically, Gross Profit has averaged $354.3 million across 5 years, with a median of $355.1 million in 2024.
• Across the five-year window, Gross Profit dropped 14.64% in 2022 and rose 6.02% in 2024, its largest moves.
• Year by year, Gross Profit stood at $397.1 million in 2022, then decreased by 7.76% to $366.3 million in 2023, then dropped by 6.63% to $342.0 million in 2024, then increased by 0.94% to $345.2 million in 2025, then dropped by 10.37% to $309.4 million in 2026.
• Per Business Quant data, the three most recent Gross Profit figures were $309.4 million in Q1 2026, $345.2 million in Q4 2025, and $343.4 million in Q3 2025.